Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in Chile

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: Chile Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20041
20051
20062
20073
20081
20101
20131
20141
20181
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi7
Bristol-Myers Squibb2
Anthos Therapeutics, Inc.1
Astellas Pharma Inc1
Boehringer Ingelheim1
CSL Behring1
Daiichi Sankyo1
Janssen Research & Development, LLC1
Janssen Scientific Affairs, LLC1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation17
Stroke4
Atrial Flutter3
Arrhythmias, Cardiac2
Cardiovascular Diseases2
Embolism2
Acute Coronary Syndrome1
Atherosclerosis1
Coronary Artery Disease1
Heart Diseases1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.